• 1. Emulsion technologies for multicellular tumour spheroid radiation assays?
  Kay S. McMillan,Anthony G. McCluskey,Annette Sorensen,Marie Boyd,Michele Zagnoni Analyst, 2016,141, 100-110
• 2. Establishing plasmon contribution to chemical reactions: alkoxyamines as a thermal probe?
  Olga Guselnikova,Gérard Audran,Jean-Patrick Joly,Andrii Trelin,Evgeny V. Tretyakov,Vaclav Svorcik,Oleksiy Lyutakov,Sylvain R. A. Marque Chem. Sci., 2021,12, 4154-4161
• 3. Dissociation of large gaseous serine clusters produces abundant protonated serine octamer
  Jacob S. Jordan,Evan R. Williams Analyst, 2021,146, 2617-2625
• 4. Excellent lithium ion storage property of porous MnCo2O4 nanorods?
  Peiyuan Zeng,Xiaoxiao Wang,Ming Ye,Qiuyang Ma,Jianwen Li,Wanwan Wang,Baoyou Geng,Zhen Fang RSC Adv., 2016,6, 23074-23084
• 5. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212

Benzyl 2-oxo-2,5-dihydro-1H-pyrrole-1-carboxylate (CAS No. 96658-35-4): A Comprehensive Overview

Benzyl 2-oxo-2,5-dihydro-1H-pyrrole-1-carboxylate, identified by its Chemical Abstracts Service (CAS) number 96658-35-4, is a significant compound in the field of pharmaceutical chemistry and bioorganic synthesis. This heterocyclic ester, derived from the pyrrole scaffold, has garnered considerable attention due to its versatile structural features and potential applications in medicinal chemistry. The compound’s unique combination of a benzyl group and a pyrrole ring system makes it a valuable intermediate in the synthesis of more complex molecules, particularly those targeting neurological and anti-inflammatory pathways.

The molecular structure of Benzyl 2-oxo-2,5-dihydro-1H-pyrrole-1-carboxylate consists of a five-membered pyrrole ring substituted with a carbonyl group at the 2-position and an ester linkage at the 1-position, further functionalized with a benzyl moiety. This configuration imparts distinct reactivity patterns, making it a useful building block for constructing pharmacophores. The presence of both electron-withdrawing and electron-donating groups within the molecule allows for diverse chemical modifications, enabling the exploration of novel therapeutic agents.

In recent years, there has been growing interest in heterocyclic compounds as pharmacological scaffolds due to their prevalence in biologically active natural products and synthetic drugs. Among these, pyrrole derivatives have shown promise in various therapeutic areas, including antiviral, antibacterial, and anticancer applications. The specific substitution pattern of Benzyl 2-oxo-2,5-dihydro-1H-pyrrole-1-carboxylate positions it as a key intermediate in the development of small-molecule inhibitors targeting enzyme-catalyzed reactions relevant to these diseases.

One of the most compelling aspects of Benzyl 2-oxo-2,5-dihydro-1H-pyrrole-1-carboxylate is its utility in the synthesis of protease inhibitors. Proteases play critical roles in numerous biological processes, and their overactivity or misregulation is associated with several pathological conditions. By serving as a precursor for molecules that can modulate protease activity, this compound contributes to the design of novel therapeutics aimed at inhibiting pathogenic enzymes. For instance, derivatives of this scaffold have been explored as potential treatments for inflammatory diseases by targeting specific proteases involved in cytokine processing.

The synthesis of Benzyl 2-oxo-2,5-dihydro-1H-pyrrole-1-carboxylate typically involves multi-step organic transformations starting from readily available precursors. Common synthetic routes include condensation reactions between β-ketoesters and ammonia or ammonium salts to form the pyrrole core, followed by esterification with benzyl alcohol or benzyl halides. Advances in catalytic methods have also enabled more efficient and scalable production processes, enhancing its accessibility for industrial applications.

Recent research has highlighted the potential of Benzyl 2-oxo-2,5-dihydro-1H-pyrrole-1-carboxylate as a precursor for bioactive molecules with antimicrobial properties. Studies have demonstrated that certain derivatives exhibit inhibitory effects against Gram-positive bacteria by interfering with essential bacterial metabolic pathways. The benzyl group provides a handle for further functionalization, allowing chemists to tailor the compound’s properties for specific biological targets. This adaptability has made it a valuable tool in drug discovery efforts aimed at combating resistant bacterial strains.

The role of computational chemistry in optimizing derivatives of Benzyl 2-oxo-2,5-dihydro-1H-pyrrole-1-carboxylate cannot be overstated. Molecular modeling techniques have enabled researchers to predict binding affinities and metabolic stability with high accuracy, streamlining the design process for new drug candidates. By integrating experimental data with computational insights, scientists can rapidly screen large libraries of derivatives to identify promising leads for further development.

In conclusion, Benzyl 2-oxo-2,5-dihydro-1H-pyrrole-1-carboxylate (CAS No. 96658-35-4) represents a versatile and strategically important compound in pharmaceutical chemistry. Its unique structural features and reactivity make it an excellent candidate for synthesizing novel therapeutic agents targeting various diseases. As research continues to uncover new applications for this compound and its derivatives, its significance in drug discovery is likely to grow further.

• 31970-04-4(Benzyl 2,5-dihydro-1H-pyrrole-1-carboxylate)
• 725746-35-0(Benzyl 2-oxo-5,6-dihydropyridine-1(2H)-carboxylate)
• 492998-46-6(1H-Pyrrole-1-carboxylic acid, 2,5-dihydro-2-oxo-4-(phenylmethoxy)-,phenylmethyl ester)
• 109853-54-5(3-(3-phenylprop-2-enoyl)-1,3-oxazolidin-2-one)
• 370880-75-4(2-(N-Cbz-N-Allylamino)-acetaldehyde)
• 1065075-80-0(Benzyl Allyl(2-hydroxyethyl)carbamate)
• 55750-51-1(1H-Pyrrole-1-carboxylicacid, 2,5-dihydro-2,5-dioxo-, phenylmethyl ester)
• 109299-93-6(2-Oxazolidinone, 3-[(2E)-1-oxo-3-phenyl-2-propenyl]-)
• 55750-49-7(Ethyl 2,5-dioxopyrrole-1-carboxylate)
• 3988-84-9(Ethyl 2-oxo-2,5-dihydro-1H-pyrrole-1-carboxylate)